IRMD

SEC source: 0000898432-20-000023 · form4.xml · nonDerivative · entry 2

JOHNSON BRENT · CIK 0001254747 · Exec. VP. of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,940

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

F2 · price: This transaction was executed in multiple trades at prices ranging from $23.50 to $23.64. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0000898432-20-000023 · form4.xml · nonDerivative · entry 1

JOHNSON BRENT · CIK 0001254747 · Exec. VP. of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,940

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

SEC source: 0000898432-20-000016 · form4.xml · derivative · entry 3

Casey Francis X. · CIK 0001613661 · VP of Reg. and Qual. Assurance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 388 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F2 · derivative.exercise_date: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 4, 2017. The scheduled January 4, 2020 vesting was accelerated by the registrant, and the restricted stock units became vested as of December 31, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

F2 · derivative.expiration_date: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 4, 2017. The scheduled January 4, 2020 vesting was accelerated by the registrant, and the restricted stock units became vested as of December 31, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

SEC source: 0000898432-20-000016 · form4.xml · nonDerivative · entry 2

Casey Francis X. · CIK 0001613661 · VP of Reg. and Qual. Assurance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,474

SEC source: 0000898432-20-000016 · form4.xml · nonDerivative · entry 1

Casey Francis X. · CIK 0001613661 · VP of Reg. and Qual. Assurance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,569

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

SEC source: 0000898432-20-000018 · form4.xml · derivative · entry 3

Waldman Louis S. · CIK 0001613666 · Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,164 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F2 · derivative.exercise_date: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 4, 2017. The scheduled January 4, 2020 vesting was accelerated by the registrant, and the restricted stock units became vested as of December 31, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

F2 · derivative.expiration_date: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 4, 2017. The scheduled January 4, 2020 vesting was accelerated by the registrant, and the restricted stock units became vested as of December 31, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

SEC source: 0000898432-20-000018 · form4.xml · nonDerivative · entry 2

Waldman Louis S. · CIK 0001613666 · Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,307

SEC source: 0000898432-20-000018 · form4.xml · nonDerivative · entry 1

Waldman Louis S. · CIK 0001613666 · Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,591

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

SEC source: 0000898432-20-000019 · form4.xml · derivative · entry 3

Nardi Steven M. · CIK 0001613663 · VP Manufacturing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 388 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F2 · derivative.exercise_date: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 4, 2017. The scheduled January 4, 2020 vesting was accelerated by the registrant, and the restricted stock units became vested as of December 31, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

F2 · derivative.expiration_date: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 4, 2017. The scheduled January 4, 2020 vesting was accelerated by the registrant, and the restricted stock units became vested as of December 31, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

SEC source: 0000898432-20-000019 · form4.xml · nonDerivative · entry 2

Nardi Steven M. · CIK 0001613663 · VP Manufacturing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,715

SEC source: 0000898432-20-000019 · form4.xml · nonDerivative · entry 1

Nardi Steven M. · CIK 0001613663 · VP Manufacturing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,810

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

SEC source: 0000898432-20-000020 · form4.xml · derivative · entry 3

Scott Christopher K. · CIK 0001613803 · CFO & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,716 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F2 · derivative.exercise_date: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 4, 2017. The scheduled January 4, 2020 vesting was accelerated by the registrant, and the restricted stock units became vested as of December 31, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

F2 · derivative.expiration_date: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 4, 2017. The scheduled January 4, 2020 vesting was accelerated by the registrant, and the restricted stock units became vested as of December 31, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

SEC source: 0000898432-20-000020 · form4.xml · nonDerivative · entry 2

Scott Christopher K. · CIK 0001613803 · CFO & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,032

SEC source: 0000898432-20-000020 · form4.xml · nonDerivative · entry 1

Scott Christopher K. · CIK 0001613803 · CFO & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,694

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

SEC source: 0000898432-20-000015 · form4.xml · derivative · entry 6

JOHNSON BRENT · CIK 0001254747 · Exec. VP. Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 126,468

Underlying: Common Stock · 6,000 shares

Expires 2022-11-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Restricted stock units convert into common stock on a one-for-one basis.

F5 · derivative.exercise_date: This option, representing a right to purchase a total of 278,408 shares, was granted on November 1, 2012 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date.

SEC source: 0000898432-20-000015 · form4.xml · derivative · entry 5

JOHNSON BRENT · CIK 0001254747 · Exec. VP. Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 617 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F2 · derivative.exercise_date: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 4, 2017. The scheduled January 4, 2020 vesting was accelerated by the registrant, and the restricted stock units became vested as of December 31, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

F2 · derivative.expiration_date: On January 4, 2016, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on January 4, 2017. The scheduled January 4, 2020 vesting was accelerated by the registrant, and the restricted stock units became vested as of December 31, 2019. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

SEC source: 0000898432-20-000015 · form4.xml · nonDerivative · entry 4

JOHNSON BRENT · CIK 0001254747 · Exec. VP. Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,940

F3 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

F4 · price: This transaction was executed in multiple trades at prices ranging from $23.65 to $23.85. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0000898432-20-000015 · form4.xml · nonDerivative · entry 3

JOHNSON BRENT · CIK 0001254747 · Exec. VP. Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,940

F3 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

SEC source: 0000898432-20-000015 · form4.xml · nonDerivative · entry 2

JOHNSON BRENT · CIK 0001254747 · Exec. VP. Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,940

SEC source: 0000898432-20-000015 · form4.xml · nonDerivative · entry 1

JOHNSON BRENT · CIK 0001254747 · Exec. VP. Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,183

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

SEC source: 0000898432-19-001530 · form4.xml · derivative · entry 6

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 132,468

Underlying: Common Stock · 8,000 shares

Expires 2022-11-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

F4 · derivative.exercise_date: This option, representing a right to purchase a total of 278,408 shares, was granted on November 1, 2012 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date.

SEC source: 0000898432-19-001530 · form4.xml · nonDerivative · entry 4

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,566

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

F3 · price: This transaction was executed in multiple trades at prices ranging from $24.02 to $24.44. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0000898432-19-001530 · form4.xml · nonDerivative · entry 3

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,566

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

SEC source: 0000898432-19-001530 · form4.xml · derivative · entry 5

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 140,468

Underlying: Common Stock · 8,000 shares

Expires 2022-11-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

F4 · derivative.exercise_date: This option, representing a right to purchase a total of 278,408 shares, was granted on November 1, 2012 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date.

SEC source: 0000898432-19-001530 · form4.xml · nonDerivative · entry 2

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,566

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

F2 · price: This transaction was executed in multiple trades at prices ranging from $24.18 to $24.35. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0000898432-19-001530 · form4.xml · nonDerivative · entry 1

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,566

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

SEC source: 0000898432-19-001524 · form4.xml · derivative · entry 9

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 148,468

Underlying: Common Stock · 8,000 shares

Expires 2022-11-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

F5 · derivative.exercise_date: This option, representing a right to purchase a total of 278,408 shares, was granted on November 1, 2012 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date.

SEC source: 0000898432-19-001524 · form4.xml · nonDerivative · entry 6

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,566

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

F4 · price: This transaction was executed in multiple trades at prices ranging from $24.29 to $25.04. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0000898432-19-001524 · form4.xml · nonDerivative · entry 5

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,566

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

SEC source: 0000898432-19-001524 · form4.xml · derivative · entry 8

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 156,468

Underlying: Common Stock · 8,000 shares

Expires 2022-11-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

F5 · derivative.exercise_date: This option, representing a right to purchase a total of 278,408 shares, was granted on November 1, 2012 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date.

SEC source: 0000898432-19-001524 · form4.xml · nonDerivative · entry 4

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,566

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

F3 · price: This transaction was executed in multiple trades at prices ranging from $24.53 to $24.73. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0000898432-19-001524 · form4.xml · nonDerivative · entry 3

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,566

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

SEC source: 0000898432-19-001524 · form4.xml · derivative · entry 7

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 164,468

Underlying: Common Stock · 8,000 shares

Expires 2022-11-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

F5 · derivative.exercise_date: This option, representing a right to purchase a total of 278,408 shares, was granted on November 1, 2012 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date.

SEC source: 0000898432-19-001524 · form4.xml · nonDerivative · entry 2

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,566

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

F2 · price: This transaction was executed in multiple trades at prices ranging from $25.00 to $25.28. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0000898432-19-001524 · form4.xml · nonDerivative · entry 1

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,566

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

SEC source: 0000898432-19-001517 · form4.xml · derivative · entry 6

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 172,468

Underlying: Common Stock · 8,000 shares

Expires 2022-11-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

F4 · derivative.exercise_date: This option, representing a right to purchase a total of 278,408 shares, was granted on November 1, 2012 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date.

SEC source: 0000898432-19-001517 · form4.xml · nonDerivative · entry 4

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,566

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

F3 · price: This transaction was executed in multiple trades at prices ranging from $25.00 to $25.54. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0000898432-19-001517 · form4.xml · nonDerivative · entry 3

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,566

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

SEC source: 0000898432-19-001517 · form4.xml · derivative · entry 5

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 180,468

Underlying: Common Stock · 8,000 shares

Expires 2022-11-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

F4 · derivative.exercise_date: This option, representing a right to purchase a total of 278,408 shares, was granted on November 1, 2012 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date.

SEC source: 0000898432-19-001517 · form4.xml · nonDerivative · entry 2

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,566

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

F2 · price: This transaction was executed in multiple trades at prices ranging from $25.47 to $25.70. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0000898432-19-001517 · form4.xml · nonDerivative · entry 1

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,566

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

SEC source: 0000898432-19-001513 · form4.xml · derivative · entry 9

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 188,468

Underlying: Common Stock · 8,000 shares

Expires 2022-11-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

F5 · derivative.exercise_date: This option, representing a right to purchase a total of 278,408 shares, was granted on November 1, 2012 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date.

SEC source: 0000898432-19-001513 · form4.xml · nonDerivative · entry 6

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,566

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

F4 · price: This transaction was executed in multiple trades at prices ranging from $25.25 to $25.33. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0000898432-19-001513 · form4.xml · nonDerivative · entry 5

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,566

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

SEC source: 0000898432-19-001513 · form4.xml · derivative · entry 8

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 196,468

Underlying: Common Stock · 8,000 shares

Expires 2022-11-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

F5 · derivative.exercise_date: This option, representing a right to purchase a total of 278,408 shares, was granted on November 1, 2012 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date.

SEC source: 0000898432-19-001513 · form4.xml · nonDerivative · entry 4

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,566

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

F3 · price: This transaction was executed in multiple trades at prices ranging from $25.05 to $25.27. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0000898432-19-001513 · form4.xml · nonDerivative · entry 3

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,566

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

SEC source: 0000898432-19-001513 · form4.xml · derivative · entry 7

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 204,468

Underlying: Common Stock · 8,000 shares

Expires 2022-11-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

F5 · derivative.exercise_date: This option, representing a right to purchase a total of 278,408 shares, was granted on November 1, 2012 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date.

SEC source: 0000898432-19-001513 · form4.xml · nonDerivative · entry 2

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,566

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.

F2 · price: This transaction was executed in multiple trades at prices ranging from $25.10 to $25.42. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0000898432-19-001513 · form4.xml · nonDerivative · entry 1

JOHNSON BRENT · CIK 0001254747 · Exec. VP of WW Sales and Mktg

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,566

F1 · kind: The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019.